| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC2907 |
| Trial ID | NCT05208853 |
| Disease | Hodgkin's Lymphoma | Peripheral T-Cell Lymphoma | Anaplastic Large Cell Lymphoma | NK/T-Cell Lymphoma | Diffuse Large B-Cell Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Gray Zone Lymphoma |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD30 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | ARM002-CN-2021-01 |
| Cohort 1 | |||||||||||
|
|||||||||||